HOTH: Dhuwit awis diétung saben siji saham hoththerapeutics.com

Hoth Therapeutics - logo grafis emiten HOTH

Hoth Therapeutics, Inc. (HOTH) is developing advanced drug delivery systems to combat cancer and psoriasis, relying on future insurance reimbursements. Cash per share for the period reflects this strategy, with the current mark standing at 0.21. The company is currently executing a planned burn of existing capital to fund intensive R&D in the absence of operating revenue.

Hoth Therapeutics Inc. (HOTH) - Dhuwit awis saben saham saka 04.07.2022 nganti 28.05.2026

Rincian metrik komprehensif lan analitis Hoth (HOTH)

- rega saham lan prakiraan rega para ahli:
- indikator anane dhuwit lan arus kas:
Analisis komprehensif perusahaan:Hoth Therapeutics (HOTH)
Barang unggulan Hoth Therapeutics Inc.

The indicator's dynamics depend directly on quarterly reporting of cash balances and the volume of share issuance. This metric determines the share of net liquid assets per security. For Hoth Therapeutics, Inc. (HOTH), this reserve is critical when conducting costly clinical trials in the US. The absence of sanctions risks stabilizes financial planning. By analyzing the current level of liquidity per share, an investor assesses the stability of the company's capital.